- Report
- July 2024
- 110 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- July 2024
- 120 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- April 2025
- 150 Pages
Global
From €4440EUR$4,850USD£3,773GBP
- Report
- March 2025
- 150 Pages
Global
From €4440EUR$4,850USD£3,773GBP
- Report
- March 2025
- 150 Pages
Global
From €4440EUR$4,850USD£3,773GBP
- Report
- March 2025
- 150 Pages
Global
From €4440EUR$4,850USD£3,773GBP
- Report
- February 2025
- 150 Pages
Global
From €4440EUR$4,850USD£3,773GBP
- Report
- December 2024
- 150 Pages
Global
From €4440EUR$4,850USD£3,773GBP
- Report
- December 2024
- 200 Pages
Global
From €3433EUR$3,750USD£2,917GBP
- Report
- August 2024
- 140 Pages
Global
From €3616EUR$3,950USD£3,073GBP
- Report
- October 2024
- 83 Pages
Global
From €4440EUR$4,850USD£3,773GBP
- Report
- October 2024
- 100 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- August 2024
- 200 Pages
Global
From €4530EUR$4,949USD£3,850GBP
- Report
- April 2025
- 179 Pages
Global
From €4572EUR$4,995USD£3,886GBP
- Report
- December 2024
- 150 Pages
Global
From €3073EUR$3,358USD£2,612GBP
€3616EUR$3,950USD£3,073GBP
- Report
- January 2025
- 50 Pages
Global
From €2288EUR$2,499USD£1,944GBP
- Report
- December 2024
- 55 Pages
Global
From €2288EUR$2,499USD£1,944GBP
- Report
- April 2025
- 220 Pages
Global
From €1645EUR$1,797USD£1,398GBP
€1828EUR$1,997USD£1,554GBP
- Newsletter
- May 2025
Global
€2742EUR$2,995USD£2,330GBP
- Report
- February 2025
- 135 Pages
Global
From €3996EUR$4,365USD£3,396GBP
€4440EUR$4,850USD£3,773GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more